Search - tctmd.com

Displaying 121 - 140 of 191

Sort: Relevancy | Date

Presentation TCT 2014

Imaging to Guide BRS: Nice to Have or Must Have?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Evelyn S. Regar

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Jonathan M. Hill

September 16, 2014

Presentation TCT 2014

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Azeem Latib

September 16, 2014

Presentation TCT 2014

BRS Under Development V Biolute BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Dinesh Shah

September 16, 2014

Presentation TCT 2014

BRS Under Development IV The Lepu BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Yaling Han

September 16, 2014

Presentation TCT 2014

BRS Under Development III The XINSORB BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Junbo Ge

September 16, 2014

Presentation TCT 2014

BRS Under Development II Meril Life Sciences

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Martin B. Leon

September 16, 2014

Presentation TCT 2014

BRS Under Development I The Manli Mirage BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Teguh Santoso

September 16, 2014

Presentation TCT 2014

BRS with Clinical Data V DREAMS: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Michael Haude

September 16, 2014

Presentation TCT 2014

BRS with Clinical Data IV ART-DIVA: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Jean Fajadet

September 16, 2014

Presentation TCT 2014

BRS with Clinical Data III Amaranth: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Juan F. Granada

September 16, 2014

Presentation TCT 2014

BRS with Clinical Data II From ReSolve to Fantom: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq

September 16, 2014

Presentation TCT 2014

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq

September 16, 2014

Presentation TCT 2014

BRS with Clinical Data I DESolve: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Stefan Verheye

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Update: The EXTEND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Alexandre Abizaid

September 16, 2014

Presentation TCT 2014

Update: The Absorb ASSURE Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Thomas Schmitz

September 16, 2014

Presentation TCT 2014

Update: The Absorb GHOST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Corrado Tamburino

September 16, 2014

Advertisement

Imaging to Guide BRS: Nice to Have or Must Have?

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Tips, Tricks, and Pearls to Optimize BRS Outcomes: From Lesion Preparation to Pharmacotherapy Considerations

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

BRS Under Development V Biolute BRS

BRS Under Development IV The Lepu BRS

BRS Under Development III The XINSORB BRS

BRS Under Development II Meril Life Sciences

BRS Under Development I The Manli Mirage BRS

BRS with Clinical Data V DREAMS: Differentiating Features and Clinical Update

BRS with Clinical Data IV ART-DIVA: Differentiating Features and Clinical Update

BRS with Clinical Data III Amaranth: Differentiating Features and Clinical Update

BRS with Clinical Data II From ReSolve to Fantom: Differentiating Features and Clinical Update

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

BRS with Clinical Data I DESolve: Differentiating Features and Clinical Update

Absorb III/IV: Testing Noninferiority and Superiority

Absorb III/IV: Angina and Ischemia Hypotheses

Update: The EXTEND Real-World Registry

Update: The Absorb ASSURE Real-World Registry

Update: The Absorb GHOST Real-World Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content